Clinic
Rushford Center INC
Rushford Center INC was paid $23.00M by Medicaid between Jan 2018 and Dec 2024, across 21 billing codes. Its largest line is H2036, Alcohol and/or other drug treatment program, per diem — 57% of everything it billed.
33Billing provider infoRUSHFORD CENTER INC
MIDDLETOWN, CT 06457
MIDDLETOWN, CT 06457
33aNPI1982813713assigned 05/21/2007
33bProvider typeSubstance Use Disorder Rehabilitation Clinic/Center
28Total paid$23.00M
24GClaims157,316
24DCodes billed21
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Substance Use Disorder Rehabilitation Clinic/Center providers in Connecticut
Rank by total paid#2 of 11
Median peer was paid$1.86M
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,209 | $1.11M | |
| 2019 | 8,366 | $921K | |
| 2020 | 9,142 | $502K | |
| 2021 | 7,158 | $404K | |
| 2022 | 44,818 | $3.80M | |
| 2023 | 47,076 | $8.45M | |
| 2024incomplete | 31,547 | $7.81M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H2036 | Alcohol and/or other drug treatment program, per diem | 57% | 66,682 | 3,484 | $13.12M |
| H0011 | Alcohol and/or drug services; acute detoxification (residential addiction program inpatient) | 26% | 13,075 | 3,246 | $5.87M |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | 8.2% | 16,083 | 2,717 | $1.89M |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | 3.1% | 3,464 | 577 | $725K |
| S9480 | Intensive outpatient psychiatric services, per diem | 2.9% | 7,126 | 1,154 | $660K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.4% | 15,743 | 6,835 | $316K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 1,790 | 1,559 | $193K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 2,293 | 1,645 | $142K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | <1% | 383 | 154 | $34K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 421 | 281 | $28K |
| 99205 | Prolong outpt/office vis | <1% | 46 | 43 | $8K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 60 | 30 | $7K |
9 more codes
| 90834 | Psychotherapy session, about 45 minutes | <1% | 85 | $5K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 71 | $3K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 0% | 1,598 | $0.00 |
| H0047 | Alcohol and/or other drug abuse services, not otherwise specified | 0% | 17,117 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 2,392 | $0.00 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 598 | $0.00 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 3,990 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 3,972 | $0.00 |
| H0018 | Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem | 0% | 327 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBABER, KATHLEEN (VICE PRESIDENT CFO)